NEW YORK, Nov. 29, 2021 /PRNewswire/ -- The "Molecular Biology Enzymes, Kits, and Reagents Market - Competitive Analysis, Drivers, Challenges & Five Force Analysis" report has been added to Technavio's offering. The molecular biology enzymes, kits, and reagents market value is set to grow by USD 13.09 billion, progressing at a CAGR of 14.61% from 2020 to 2025.
For more insights on the Molecular Biology Enzymes, Kits, and Reagents Market -Download a free sample now!
39% of the market's growth will originate from North America. The US is a key market for molecular biology enzymes, kits, and reagents in the region. The rising incidence of infectious diseases and genetic disorders will facilitate the molecular biology enzymes, kits, and reagents market growth in North America. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.
Factors such as increased use of proteins and reagents in biotechnology and pharmaceutical companies and the rising number of genome projects will drive the growth of the Molecular Biology Enzymes, Kits, And Reagents Market. However, privacy issues concerning data leakage of genetic information might hamper market growth. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.
The molecular biology enzymes, kits, and reagents market are fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The molecular biology enzymes, kits, and reagents market report provide complete insights on key vendors including Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.
Few Companies with Key Offerings
Agilent Technologies Inc.- The company offers polymerase chain reaction (PCR) enzymes and reagents, inhibitors, and kits for various applications such as reverse transcriptase cloning, cDNA from an RNA template, and high-fidelity cloning
F. Hoffmann-La Roche Ltd. - The company offers a range of molecular biology enzymes, kits, and reagents under its subsidiary Kapa Biosystems, Inc.
Illumina Inc. - The company offers a range of common molecular biology reagents such as ribosomal RNA removal reagents, DNA/RNA extraction kits, PCR reagents, and others.
The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
By End-user, the market is classified into biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and academic institutes and research organizations. The molecular biology enzymes, kits, and reagents market share growth by the biotechnology and pharmaceutical companies segment has been significant
By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.
Related Reports -
Metabolomics Market -The metabolomics market share should rise by USD 1.99 billion from 2021 to 2025 at a CAGR of 11.84%.Download a free sample now!
Immunoprotein Diagnostic Testing Market - The immunoprotein diagnostic testing market has the potential to grow by USD 11.48 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 8.64%. Download a free sample now!
Molecular Biology Enzymes, Kits, And Reagents Market Scope
Growth momentum & CAGR
Accelerate at a CAGR of 14.61%
Market growth 2021-2025
USD 13.09 billion
YoY growth (%)
North America, Europe, Asia, and ROW
Performing market contribution
North America at 39%
Key consumer countries
US, Germany, UK, China, and Japan
Leading companies, competitive strategies, consumer engagement scope
Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc. , Takara Bio Inc., and Thermo Fisher Scientific Inc.
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View original content to download multimedia:https://www.prnewswire.com/news-releases/usd-13-09-bn-growth-in-molecular-biology-enzymes-kits-and-reagents-market--evolving-opportunities-with-agilent-technologies-inc--f-hoffmann-la-roche-ltd--17000--technavio-reports-301432363.html